We found that a low concentration of senkyunolide H had no significant inhibitory effect on breast cancer cells, but a low concentration of senkyunolide H significantly reversed the promoting effect of IL-8 on breast cancer cell proliferation (Fig. 4C and E). Here, CXCL8 is linked to breast carcinoma.